相关实验视频
Updated: Jun 12, 2026
10:58
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
11.4K
沉默的威胁:在成功治疗卵巢癌后延迟大脑转移
Fatema Hashem Rupa1, Mohammad Ashraful Amin2,3,4
1General of Health Services (DGHS) Dhaka Bangladesh.
Clinical case reports
|September 26, 2025
概括
卵巢癌引起的大脑转移是罕见但严重的. 低分离立体辐射疗法 (SRT) 提供了一个可行的治疗选择,在一个案例研究中证明了症状缓解.
科学领域:
- 神经瘤学神经瘤学
- 妇科瘤学 妇科瘤学
背景情况:
- 卵巢癌引起的大脑转移并不常见,发生在0.49%~6.1%的病例中.
- 这些转移与预后不佳有关,平均存活时间为210个月.
- 预后受到患者年龄,表现状况,脑外疾病程度和脑转移数量的影响.
研究的目的:
- 为了呈现卵巢癌的病例与晚期发作的大脑转移.
- 评估低分离立体辐射疗法 (SRT) 在管理这些转移中的疗效和安全性.
主要方法:
- 一名52岁的妇女患有第三阶段卵巢癌,缓解了十年,出现了神经症状.
- 部MRI显示了两个大脑病变,用低分数SRT (27 Gy/3次和30 Gy/5次) 治疗.
- 由于内压力,治疗暂时暂停,用皮质类固醇和曼尼托尔进行管理,随后进行辅助性Temozolomide化疗.
主要成果:
- 患者在低分离的SRT后经历了症状缓解.
- 尽管最初出现了并发症,但治疗成功完成.
- 在放射治疗后开始使用Temozolomide的辅助化疗.
结论:
- 低分化SRT是一种可行的治疗卵巢癌患者大脑转移的治疗方法.
- 个性化护理和多学科方法对于管理并发症和优化结果至关重要.
- 这一案例凸显了长期缓解和晚期发生的大脑转移的有效管理的潜力.
相关概念视频
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...